<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    DiaMedica Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC." Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Rick Pauls
    • FOUNDED
      2000
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology was formed to acquire a portfolio of various medical lice...

    Global Cancer Technology was formed to acquire ...

    Fundraising Status:    EC
    Filing Type:    RA
    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc. (“Checkpoint”) is a clinical-stage, immuno-oncol...

    Checkpoint Therapeutics, Inc. (“Checkpoint”...

    Filing Type:    PU
    Reckitt Benckiser Group Plc.

    Reckitt Benckiser Group Plc.

    RB is the global leading consumer health, hygiene and home company. Driven by a pu...

    RB is the global leading consumer health, hygie...

    Filing Type:    PU
    Adamis Pharmaceuticals Corporation

    Adamis Pharmaceuticals Corporation

    Founded in 2006 and headquartered in San Diego, Adamis (ADMP) is a specialty bioph...

    Founded in 2006 and headquartered in San Diego,...

    Filing Type:    PU
    Neurotez Inc.

    Neurotez Inc.

    We have used biochemical, molecular & cell biology and in vivo models to screen, i...

    We have used biochemical, molecular & cell biol...

    Amount Raised:    $7,656.00
    Fundraising Status:    EC
    Filing Type:    CF
    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company th...

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a ...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Rockwell Medical, Inc.

    Rockwell Medical, Inc.

    Rockwell Medical (NASDAQ: RMTI) is a fully-integrated biopharmaceutical company ta...

    Rockwell Medical (NASDAQ: RMTI) is a fully-inte...

    Filing Type:    PU
    Proteon Therapeutics, Inc.

    Proteon Therapeutics, Inc.

    Proteon Therapeutics is working to deliver a new future for patients and families ...

    Proteon Therapeutics is working to deliver a ne...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.